Company intelligence / Profile preview
Synergistic Therapeutics
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
Overview
Synergistic Therapeutics is a private Florida specialty pharmaceutical company focused on topical and sublingual formulations for neuropsychiatric, pain, addiction, and dermatologic-related conditions. The company markets branded products including Dolore for pain, Minervo for neuropathic pain, Cresere for hair growth, Felicita for depression and anxiety, and Smettere for substance abuse disorder and opioid dependency. It emphasizes patented and proprietary delivery approaches, including a patented sublingual ketamine lozenge and topical formulations designed for enhanced skin penetration. The company also highlights aseptic processing, CGMP-oriented quality systems, and personalized as well as commercially available medication offerings. Beyond marketed products, it describes additional R&D efforts in postpartum depression, PTSD, bipolar disorder, OCD, PMDD, and sexual dysfunction.
- Therapeutic areas
- Women's HealthNeurologyDermatologyPsychiatryMen's Health
- Modalities
- Small moleculeTopical therapySublingual therapy
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Synergistic Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Synergistic Therapeutics.